FDA
neuroscience
research
study
trial
CDC
biotech
High Times
•
Mon, Apr 15

Psilocybin Mental Health Therapy ‘Not Associated’ With Paranoia Risk, Study Shows

Tom Angell
•
Sun, Apr 14

Watch Live: FDA Commissioner Testifies On Hemp Regulatory Issues At Congressional Hearing

www.marijuanamoment.net
0
Javier Gasse
•
Fri, Apr 12

FDA Commissioner To House Committee: 'There's No Reason For DEA To Delay' Cannabis Rescheduling

www.benzinga.com
5273
Peter Grinspoon
•
Fri, Apr 12

Cannabis for Harm Reduction: Study Results and Discussion from the Cannabis Center of Excellence

www.cannabissciencetech.com
5543
Marijuana Business Daily
•
Fri, Apr 12

‘No reason’ for DEA to delay marijuana rescheduling, FDA chief says

Green Market Report
•
Fri, Apr 12

FDA Commissioner suggests there is no reason for a DEA delay on rescheduling

Marijuana Moment
•
Fri, Apr 12

FDA head tells DEA to not delay cannabis rescheduling (Newsletter: April 12, 2024)

High Times
•
Fri, Apr 12

U.K. Researchers Report Finding Xylazine in Illicit Weed Vapes

Javier Gasse
•
Thu, Apr 11

New Study Reveals One Cannabis Terpene Significantly Reduces THC-Caused Anxiety

www.benzinga.com
5311
Ben Kovler
•
Thu, Apr 11

Watch Live: FDA Commissioner Testifies On Hemp Regulatory Issues At Congressional Hearing

www.marijuanamoment.net
552856